Small molecule therapeutics for schizophrenia /

The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry i...

Full description

Bibliographic Details
Other Authors:	Celanire, Sylvain (Editor), Cesura, A. M (Andrea M.) (Contributor), Poli, Sonia, active 2015 (Editor)
Format:	Book
Language:	English
Published:	Cham : Springer, [2015]
Series:	Topics in medicinal chemistry (Springer (Firm)) ; 13
Subjects:	Schizophrenia > Chemotherapy Schizophrenia > drug therapy Biochemistry Chemistry HEALTH & FITNESS > Diseases > General MEDICAL > Clinical Medicine Neurosciences Psychopharmacology Schizophrenia > Chemotherapy > Juvenile literature Schizophrenia > Chemotherapy Schizophrenia > Treatment > Juvenile literature HEALTH & FITNESS > Diseases > General MEDICAL > Clinical Medicine MEDICAL > Diseases MEDICAL > Evidence-Based Medicine MEDICAL > Internal Medicine chemie chemistry farmacologie geneeskunde medicine neuroscience neurowetenschap pharmacology Chemie (algemeen) Chemistry (General) Electronic books


LEADER	06536nam a2201093Ii 4500
001	ef7bb98c-7494-4a64-aaa7-41e5ed9f0bc7
005	20240812000000.0
008	141105t20152015sz a ob 001 0 eng d
015			\|a GBB948948 \|2 bnb
016	7		\|a 019287570 \|2 Uk
019			\|a 896834350 \|a 908088801
020			\|a 3319115014 \|q (print)
020			\|a 3319115022 \|q (electronic bk.)
020			\|a 3319115022 \|q electronic bk
020			\|a 3319115030
020			\|a 3319378945
020			\|a 9783319115016 \|q (print)
020			\|a 9783319115023 \|q (electronic bk.)
020			\|a 9783319115023 \|q electronic bk
020			\|a 9783319115030 \|q (print)
020			\|a 9783319378947 \|q (print)
020			\|z 9783319115016
024	7		\|a 10.1007/978-3-319-11502-3 \|2 doi
035			\|a (OCoLC)894508352 \|z (OCoLC)896834350 \|z (OCoLC)908088801 \|z (OCoLC)1005824026 \|z (OCoLC)1048178897 \|z (OCoLC)1058271516 \|z (OCoLC)1066689192 \|z (OCoLC)1103254607 \|z (OCoLC)1112593386 \|z (OCoLC)1127184042 \|z (OCoLC)1131973175
035			\|a (OCoLC)894508352 \|z (OCoLC)896834350 \|z (OCoLC)908088801
037			\|a com.springer.onix.9783319115023 \|b Springer Nature
040			\|a N$T \|b eng \|e rda \|e pn \|c N$T \|d GW5XE \|d N$T \|d YDXCP \|d COO \|d OCLCQ \|d OCLCF \|d OHI \|d E7B \|d VLB \|d EBLCP \|d JG0 \|d IAO \|d IAS \|d JBG \|d IAD \|d SOI \|d ILO \|d UAB \|d ESU \|d OCLCQ \|d VT2 \|d IOG \|d REB \|d U3W \|d CEF \|d OCLCQ \|d INT \|d OCLCQ \|d WYU \|d OCLCO \|d OCLCA \|d UWO \|d MERER \|d AU@ \|d OCLCQ \|d OCLCO \|d UKMGB \|d OCLCO \|d AUD \|d OCLCO \|d ERF \|d OCLCQ \|d WURST \|d OCLCA \|d AJS \|d CSt
040			\|a N$T \|b eng \|e rda \|e pn \|c N$T \|d GW5XE \|d N$T \|d YDXCP \|d COO \|d OCLCQ \|d OCLCF \|d OHI \|d E7B \|d VLB \|d EBLCP \|d JG0 \|d IAO \|d IAS \|d JBG \|d IAD \|d SOI \|d ILO \|d UAB
049			\|a MAIN
050		4	\|a RC514 \|b .S62 2015eb
060		4	\|a WM 203
072		7	\|a HEA \|x 039000 \|2 bisacsh
072		7	\|a MED \|x 014000 \|2 bisacsh
072		7	\|a MED \|x 022000 \|2 bisacsh
072		7	\|a MED \|x 045000 \|2 bisacsh
072		7	\|a MED \|x 112000 \|2 bisacsh
072		7	\|a PSB \|2 bicssc
072		7	\|a PSB \|2 thema
082	0	4	\|a 616.89/806 \|2 23
245	0	0	\|a Small molecule therapeutics for schizophrenia / \|c Sylvain Celanire, Sonia Poli, editors ; with contributions by A.M. Cesura ... [and more]
264		1	\|a Cham : \|b Springer, \|c [2015]
264		4	\|c ©2015
300			\|a 1 online resource (vii, 323 pages) : \|b illustrations (some color)
336			\|a text \|b txt \|2 rdacontent
337			\|a computer \|b c \|2 rdamedia
338			\|a online resource \|b cr \|2 rdacarrier
347			\|a text file \|b PDF \|2 rda
490	1		\|a Topics in Medicinal Chemistry, \|x 1862-2461 ; \|v 13
504			\|a Includes bibliographical references and index
505	0		\|a Antipsychotics and the Dopamine-Serotonin Connection -- GLYT1 Inhibitors: From Hits to Clinical Candidates -- Metabotropic Glutamate Receptor 2 Activators -- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders -- Muscarinic Acetylcholine Receptor Activators -- Nicotinic Acetylcholine Receptor Modulators -- The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia
520			\|a The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine
546			\|a English
588	0		\|a Online resource; title from PDF title page (SpringerLink, viewed November 7, 2014)
596			\|a 22
650		0	\|a Schizophrenia \|x Chemotherapy
650		2	\|a Schizophrenia \|x drug therapy
650		4	\|a Biochemistry
650		4	\|a Chemistry
650		4	\|a HEALTH & FITNESS -- Diseases -- General
650		4	\|a MEDICAL -- Clinical Medicine
650		4	\|a Neurosciences
650		4	\|a Psychopharmacology
650		4	\|a Schizophrenia -- Chemotherapy -- Juvenile literature
650		4	\|a Schizophrenia -- Chemotherapy
650		4	\|a Schizophrenia -- Treatment -- Juvenile literature
650		7	\|a HEALTH & FITNESS \|x Diseases \|x General \|2 bisacsh
650		7	\|a MEDICAL \|x Clinical Medicine \|2 bisacsh
650		7	\|a MEDICAL \|x Diseases \|2 bisacsh
650		7	\|a MEDICAL \|x Evidence-Based Medicine \|2 bisacsh
650		7	\|a MEDICAL \|x Internal Medicine \|2 bisacsh
650		7	\|a Schizophrenia \|x Chemotherapy \|2 fast
653	0	0	\|a chemie
653	0	0	\|a chemistry
653	0	0	\|a farmacologie
653	0	0	\|a geneeskunde
653	0	0	\|a medicine
653	0	0	\|a neuroscience
653	0	0	\|a neurowetenschap
653	0	0	\|a pharmacology
653	1	0	\|a Chemie (algemeen)
653	1	0	\|a Chemistry (General)
655		0	\|a Electronic books
655		4	\|a Electronic books
700	1		\|a Celanire, Sylvain, \|e editor \|1 http://viaf.org/viaf/313571655
700	1		\|a Celanire, Sylvain, \|e editor
700	1		\|a Cesura, A. M \|q (Andrea M.), \|e contributor. \|1 http://viaf.org/viaf/1877159474355327662876
700	1		\|a Cesura, A. M \|q (Andrea M.), \|e contributor. \|? UNAUTHORIZED
700	1		\|a Poli, Sonia, \|d active 2015, \|e editor \|1 http://viaf.org/viaf/315177810
700	1		\|a Poli, Sonia, \|d active 2015, \|e editor \|? UNAUTHORIZED
776	0	8	\|i Printed edition: \|z 9783319115016
830		0	\|a Topics in medicinal chemistry (Springer (Firm)) ; \|v 13
999	1	0	\|i ef7bb98c-7494-4a64-aaa7-41e5ed9f0bc7 \|l a10724148 \|s US-CST \|m small_molecule_therapeutics_for_schizophrenia______________________________2015_______sprina___________________________________________________________________________e
999	1	0	\|i ef7bb98c-7494-4a64-aaa7-41e5ed9f0bc7 \|l 11088945 \|s US-ICU \|m small_molecule_therapeutics_for_schizophrenia______________________________2015_______sprina___________________________________________________________________________e
999	1	1	\|l a10724148 \|s ISIL:US-CST \|t BKS \|a SUL INTERNET \|b 10724148-1001 \|c INTERNET RESOURCE \|d ASIS \|x SUL \|y 10724148-1001 \|p UNLOANABLE

Small molecule therapeutics for schizophrenia /

Similar Items